Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
Total Valuation
Belite Bio, Inc. ADR has a market cap or net worth of $7.03B. The enterprise value is $6.68B.
Market Cap$7.03B
Enterprise Value$6.68B
Share Statistics
Belite Bio, Inc. ADR has 39,965,313 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding39,965,313
Owned by Insiders―
Owned by Institutions15.44%
Financial Efficiency
Belite Bio, Inc. ADR’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -10.92%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)-10.92%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee0.00
Profits Per Employee-3.10M
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Belite Bio, Inc. ADR is ―. Belite Bio, Inc. ADR’s PEG ratio is -0.72.
PE Ratio―
PS Ratio0.00
PB Ratio6.96
Price to Fair Value6.96
Price to FCF-144.35
Price to Operating Cash Flow-548.33
PEG Ratio-0.72
Income Statement
In the last 12 months, Belite Bio, Inc. ADR had revenue of 0.00 and earned -77.61M in profits. Earnings per share was -2.31.
Revenue0.00
Gross Profit0.00
Operating Income-84.21M
Pretax Income-77.61M
Net Income-77.61M
EBITDA-84.21M
Earnings Per Share (EPS)-2.31
Cash Flow
In the last 12 months, operating cash flow was -10.38M and capital expenditures -178.00K, giving a free cash flow of -10.56M billion.
Operating Cash Flow-10.38M
Free Cash Flow-10.56M
Free Cash Flow per Share-0.26
Dividends & Yields
Belite Bio, Inc. ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change224.37%
50-Day Moving Average171.14
200-Day Moving Average115.69
Relative Strength Index (RSI)55.13
Average Volume (3m)64.23K
Important Dates
Belite Bio, Inc. ADR upcoming earnings date is May 19, 2026, Before Open (Confirmed).
Last Earnings DateMar 2, 2026
Next Earnings DateMay 19, 2026
Ex-Dividend Date―
Financial Position
Belite Bio, Inc. ADR as a current ratio of 50.02, with Debt / Equity ratio of 0.06%
Current Ratio50.02
Quick Ratio50.02
Debt to Market Cap0.00
Net Debt to EBITDA4.19
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Belite Bio, Inc. ADR has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Belite Bio, Inc. ADR EV to EBITDA ratio is -59.52, with an EV/FCF ratio of -134.86.
EV to Sales0.00
EV to EBITDA-59.52
EV to Free Cash Flow-134.86
EV to Operating Cash Flow-135.51
Balance Sheet
Belite Bio, Inc. ADR has $492.42M in cash and marketable securities with $429.00K in debt, giving a net cash position of $491.99M billion.
Cash & Marketable Securities$492.42M
Total Debt$429.00K
Net Cash$491.99M
Net Cash Per Share$12.31
Tangible Book Value Per Share$22.83
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Belite Bio, Inc. ADR is $215.29, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$215.29
Price Target Upside26.80% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast-73.27%